Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Esophagitis, Difficulty swallowing (dysphagia), Increased total eosinophil count, and Vomiting and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Esophagitis, Difficulty swallowing (dysphagia), Vomiting |
Biomarker and diagnostic research for esophagitis, eosinophilic, 1 has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
212 publications have been identified in PubMed for esophagitis, eosinophilic, 1. Research spans Review / Meta-Analysis (37%), Epidemiology / Natural History (24%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 79 |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
Online Mendelian Inheritance in Man
1 |
Difficulty swallowing (dysphagia) |
Growth and development | 1 | Failure to thrive |
Disease patterns and progression | 50 | 24% |
Clinical study results | 30 | 14% |
Laboratory research | 26 | 12% |
Testing and diagnosis research | 10 | 5% |
Patient case studies | 10 | 5% |
Other research | 5 | 2% |
New treatment approaches | 2 | 1% |
Rochman M (2026). [PMID: 41386478](https://pubmed.ncbi.nlm.nih.gov/41386478/). *J Allergy Clin Immunol*. [Review / Meta-Analysis]
Savarino EV (2026). [PMID: 41877249](https://pubmed.ncbi.nlm.nih.gov/41877249/). *Ital J Pediatr*. [Review / Meta-Analysis]
Uchida AM (2026). [PMID: 41972233](https://pubmed.ncbi.nlm.nih.gov/41972233/). *Inflamm Intest Dis*. [Review / Meta-Analysis]
Bertin L (2026). [PMID: 41125460](https://pubmed.ncbi.nlm.nih.gov/41125460/). *Dig Liver Dis*. [Review / Meta-Analysis]
Wei X (2026). [PMID: 41954923](https://pubmed.ncbi.nlm.nih.gov/41954923/). *Clin Exp Immunol*. [Basic Science / Preclinical]
Bel Imam M (2026). [PMID: 41940247](https://pubmed.ncbi.nlm.nih.gov/41940247/). *Inflamm Intest Dis*. [Review / Meta-Analysis]
Ma C (2026). [PMID: 40991676](https://pubmed.ncbi.nlm.nih.gov/40991676/). *Eur J Gastroenterol Hepatol*. [Epidemiology / Natural History]
Kennedy KV (2026). [PMID: 40819800](https://pubmed.ncbi.nlm.nih.gov/40819800/). *Gastroenterology*. [Clinical Trial Publication]
Isa HM (2026). [PMID: 41905826](https://pubmed.ncbi.nlm.nih.gov/41905826/). *Pediatr Neonatol*. [Epidemiology / Natural History]
Russin M (2026). [PMID: 41581952](https://pubmed.ncbi.nlm.nih.gov/41581952/). *Gastroenterol Clin North Am*. [Review / Meta-Analysis]
AI-curated news mentioning esophagitis, eosinophilic, 1
Updated Aug 27, 2026
AstraZeneca and Amgen achieve a late-stage success for Tezspire in treating esophagitis, paving the way for another FDA submission. This follows the drug's recent expansion into chronic rhinosinusitis, enhancing its therapeutic profile.